Semaglutide

Semaglutide is recommended for:

• Adults with a BMI of 30 or greater.
• Adults with a BMI of 27 to 29.9 who have at least one weight-related health issue such as high blood pressure, high cholesterol, triglycerides, diabetes, or pre-diabetes.

Semaglutide may cause side effects, which are typically mild and occur most often at the beginning of treatment. Common side effects include:

• Nausea and vomiting
• Belching
• Diarrhea
• Stomach pain
• Constipation

Semaglutide is offered in multiple formulations:

• A weekly injection for diabetes management.
• A daily oral tablet used for diabetes management.
• A weekly injection that has received approval specifically for obesity treatment.

While some patients notice effects immediately, the maximum effect may take several months. Providers typically start with a low dose and increase it gradually over four months. Significant appetite suppression and weight loss may be more noticeable at higher dosages.

Semaglutide is administered as a once-weekly self-injection. The typical dosage progression is:

• First 4 weeks: 0.25 mg per week
• Second month: 0.5 mg per week
• Third month: 1 mg per week
• Fourth month and beyond: Up to 2 mg per week, depending on tolerance and effectiveness

Yes, compounded Semaglutide is safe. Compounding pharmacies offer injectable generic Semaglutide, which has the same active ingredient and safety profile as the brand name versions.

Semaglutide is approved for chronic weight management, meaning it can be prescribed for as long as needed. The medication is designed for long-term use to support ongoing weight loss and maintenance.